FDA Approves Polarizing First Drug for Duchenne Muscular Dystrophy

On Monday morning, the FDA controversially approved the first drug for Duchenne muscular dystrophy. Read more on how the drug works and what impact this will have in healthcare and medicine!

Advertisements

CRISPR: The Future of Science is Here

CRISPR, the latest genome-editing technology, has been making the headlines in almost every major science journal, heralding a “new era” for science. Why is CRISPR such a big deal? Better yet, what is CRISPR?

New Study Helps Decode Inherited Heart Disease

Two weeks ago President Barack Obama gave his State of the Union Address where he unveiled his Precision Medicine Initiative, which relies on genomics to “deliver the right treatment at the right time.” While NAG’s focus has been to deliver genomic medicine to physicians and patients around the country, we delight in the growing support…

Genetic Counseling Central in Clinical Genomics

As broader, more accurate genetic tests reach the market, Certified Genetic Counselors (CGC) will remain an important part of the process of delivering this information to the patient. Genomics isn’t solely about genetic testing, it’s about understanding and contextualizing all hereditary information available for a patient in order to better understand their health.This includes genotype,…

New Rules Empower Patients to Access Data

Have you heard of the new rules requiring labs to provide test results directly to patients? Here is a brief summary of the new rules: the order, issued by the U.S. Department of Health & Human Services (HHS), amends the Health Insurance Portability and Accountability Act (HIPAA) and the Clinical Laboratory Improvement Act (CLIA) to…

Genomics Only Revolutionary With Broad Access

There are many barriers currently in place preventing patients from getting their DNA sequenced, especially among minorities. Many facilities offer limited testing in the form of gene panels, but they are expensive, and often require patients to pay out of pocket. While out of pocket spending rises with income, the strain of this type of…

Advances in Alzheimer’s Prevention Made Possible by Genomics

In 2013, more than 5 million people in the United States were living with Alzheimer’s disease. That number is expected to triple by 2050. Alzheimer’s is the most common form of dementia, and can be an emotional drain on family members of those affected. Treatments can slow or delay symptoms, but there is no known…

Is Cancer Overdiagnosed?

There is a growing debate in healthcare, spurred by an advisory panel for National Cancer Institute, that says cancer is being over-diagnosed. There is no doubt that early-detection of cancer has saved lives, especially for the more aggressive varieties. The argument goes that early-detection screenings have become more widespread, but doctors still aren’t catching a…